tradingkey.logo

Niagen Bioscience Inc

NAGE
查看详细走势图
6.510USD
-0.200-2.98%
收盘 12/23, 16:00美东报价延迟15分钟
518.45M总市值
24.82市盈率 TTM

Niagen Bioscience Inc

6.510
-0.200-2.98%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.98%

5天

+2.68%

1月

-5.38%

6月

-51.56%

今年开始到现在

+22.71%

1年

+22.83%

查看详细走势图

TradingKey Niagen Bioscience Inc股票评分

单位: USD 更新时间: 2025-12-22

操作建议

Niagen Bioscience Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名45/404位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价15.80。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Niagen Bioscience Inc评分

相关信息

行业排名
45 / 404
全市场排名
140 / 4578
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 5 位分析师
买入
评级
15.800
目标均价
+143.45%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Niagen Bioscience Inc亮点

亮点风险
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
业绩高增长
公司营业收入稳步增长,连续3年增长38.23%
业绩增长期
公司处于发展阶段,最新年度总收入99.60M美元
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值25.58,处于3年历史高位
机构加仓
最新机构持股29.97M股,环比增加2.62%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值5.11K

Niagen Bioscience Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Niagen Bioscience Inc简介

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代码NAGE
公司Niagen Bioscience Inc
CEOFried (Robert N)
网址https://www.niagenbioscience.com/

常见问题

Niagen Bioscience Inc(NAGE)的当前股价是多少?

Niagen Bioscience Inc(NAGE)的当前股价是 6.510。

Niagen Bioscience Inc的股票代码是什么?

Niagen Bioscience Inc的股票代码是NAGE。

Niagen Bioscience Inc股票的52周最高点是多少?

Niagen Bioscience Inc股票的52周最高点是14.690。

Niagen Bioscience Inc股票的52周最低点是多少?

Niagen Bioscience Inc股票的52周最低点是5.160。

Niagen Bioscience Inc的市值是多少?

Niagen Bioscience Inc的市值是518.45M。

Niagen Bioscience Inc的净利润是多少?

Niagen Bioscience Inc的净利润为8.55M。

现在Niagen Bioscience Inc(NAGE)的股票是买入、持有还是卖出?

根据分析师评级,Niagen Bioscience Inc(NAGE)的总体评级为买入,目标价格为15.800。

Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是多少

Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是0.262。
KeyAI